Additional Details

  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    The Lung Research Center, LLC
    Chesterfield MO. 63017
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    Weill Cornell Medical College
    New York NY. 10065
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    University of Minnesota
    Minneapolis MN. 55455
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    University of Cincinnati Medical Center
    Cincinnati OH. 45267
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    Massachusetts General Hospital
    Boston MA. 02114
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    University of Iowa Hospitals and Clinics
    Iowa City IA. 52242
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    University of Florida
    Gainesville FL. 32611
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    The Oregon Clinic
    Portland OR. 97220
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    University of Kansas Medical Center
    Kansas City KS. 66103-2937
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    Columbia University Medical Center-New York Presbyterian Hospital
    New York NY. 10032
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    University of Virginia Health System
    Charlottesville VA. 22908
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    Duke University Medical Center
    Durham NC. 27710
    View Details
  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    Clinical Trials Center of Middle Tennessee, LLC
    Franklin TN. 37067
    View Details
  • Inspiratory Work of Breathing Before and After Extubation

    Toronto General Hospital, University Health Network
    Toronto ON. M5G2C4
    View Details
  • Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

    Weill Cornell Medicine
    New York NY. 10065
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Birmingham, AL
    Birmingham AL. 35233
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Baltimore, MD
    Baltimore MD. 21224
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Detroit, MI
    Detroit MI. 48202
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Trois-Rivières, Quebec
    Trois-Rivières QC. G8T 7A1
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Kansas City, KS
    Kansas City KS. 66160
    View Details